These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 16380836)

  • 1. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.
    Walling J
    Invest New Drugs; 2006 Jan; 24(1):37-77. PubMed ID: 16380836
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of pemetrexed in lung cancer.
    Wang D; He J
    Curr Drug Targets; 2010 Jan; 11(1):1. PubMed ID: 20017724
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical development of Alimta (Pemetrexed, LY231514), a multitargeted antifolate.
    Schultz RM
    Prog Drug Res; 2005; 63():275-300. PubMed ID: 16265884
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.
    Villela LR; Stanford BL; Shah SR
    Pharmacotherapy; 2006 May; 26(5):641-54. PubMed ID: 16637794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Folic acid antagonists pemetrexed].
    Heinzl S
    Med Monatsschr Pharm; 2004 Jul; 27(7):220-2. PubMed ID: 15296355
    [No Abstract]   [Full Text] [Related]  

  • 6. Enter Alimta: a new generation antifolate.
    Zhao R; Goldman ID
    Oncologist; 2004; 9(3):242-4. PubMed ID: 15169978
    [No Abstract]   [Full Text] [Related]  

  • 7. Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors.
    Adjei AA
    Ann Oncol; 2000 Oct; 11(10):1335-41. PubMed ID: 11106124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
    Jones RJ; Twelves CJ
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed disodium, a novel antifolate with multiple targets.
    Curtin NJ; Hughes AN
    Lancet Oncol; 2001 May; 2(5):298-306. PubMed ID: 11905785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
    Manegold C
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed in malignant pleural mesothelioma.
    Gatzemeier U
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):26-31. PubMed ID: 15655933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed in bladder, head and neck, and cervical cancers.
    Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998.
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578
    [No Abstract]   [Full Text] [Related]  

  • 14. Positioning pemetrexed in the treatment of ovarian cancer.
    Ledermann JA; Stebbing J
    Eur J Cancer; 2009 May; 45(8):1330-2. PubMed ID: 19264477
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of pemetrexed in the treatment of colorectal cancer.
    Hochster H
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifolates: the next millennium.
    Allegra CJ
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-2. PubMed ID: 10598548
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifolates in clinical development.
    Takimoto CH
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-40-S18-51. PubMed ID: 9420020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pemetrexed: from preclinic to clinic].
    Lansiaux A; Lokiec F
    Bull Cancer; 2007; 94 Spec No Actualites():S134-8. PubMed ID: 17845983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current state of pemetrexed in ovarian cancer.
    Miller RE; Banerjee S
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1201-10. PubMed ID: 23899335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.